Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia

被引:200
作者
Letteboer, TGW
Mager, JJ
Snijder, RJ
Koeleman, BPC
Lindhout, D
van Amstel, JKP
Westermann, CJJ
机构
[1] Univ Med Ctr Utrecht, DBG Dept Med Genet, NL-3508 AB Utrecht, Netherlands
[2] St Antonius Hosp, Nieuwegein, Netherlands
关键词
D O I
10.1136/jmg.2005.035451
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterised by vascular malformations in multiple organ systems, resulting in mucocutaneous telangiectases and arteriovenous malformations predominantly in the lungs ( pulmonary arteriovenous malformation; PAVM), brain ( cerebral arteriovenous malformation; CAVM), and liver ( hepatic arteriovenous malformation; HAVM). Mutations in the ENG and ALK-1 genes lead to HHT1 and HHT2 respectively. In this study, a genotype-phenotype analysis was performed. A uniform and well classified large group of HHT patients and their family members were screened for HHT manifestations. Groups of patients with a clinically confirmed diagnosis and/ or genetically established diagnosis ( HHT1 or HHT2) were compared. The frequency of PAVM, CAVM, HAVM, and gastrointestinal telangiectases were determined to establish the genotype-phenotype relationship. The analysis revealed differences between HHT1 and HHT2 and within HHT1 and HHT2 between men and women. PAVMs and CAVMs occur more often in HHT1, whereas HAVMs are more frequent in HHT2. Furthermore, there is a higher prevalence of PAVM in women compared with men in HHT1. In HHT1 and HHT2, there is a higher frequency of HAVM in women. HHT1 has a distinct, more severe phenotype than HHT2. There is a difference in the presence of symptoms between men and women. With these data, genetic counselling can be given more accurately when the family mutation is known.
引用
收藏
页码:371 / 377
页数:7
相关论文
共 31 条
[1]   Visceral manifestations in hereditary haemorrhagic telangiectasia type 2 [J].
Abdalla, SA ;
Geisthoff, UW ;
Bonneau, D ;
Plauchu, H ;
McDonald, J ;
Kennedy, S ;
Faughnan, ME ;
Letarte, M .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (07) :494-502
[2]   Disease-associated mutations in conserved residues of ALK-1 kinase domain [J].
Abdalla, SA ;
Cymerman, U ;
Johnson, RM ;
Deber, CM ;
Letarte, M .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2003, 11 (04) :279-287
[3]   Hereditary haemorrhagic telangiectasia:: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations [J].
Berg, J ;
Porteous, M ;
Reinhardt, D ;
Gallione, C ;
Holloway, S ;
Umasunthar, T ;
Lux, A ;
McKinnon, W ;
Marchuk, D ;
Guttmacher, A .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (08) :585-590
[4]   Clinical heterogeneity in hereditary haemorrhagic telangiectasia: Are pulmonary arteriovenous malformations more common in families linked to endoglin? [J].
Berg, JN ;
Guttmacher, AE ;
Marchuk, DA ;
Porteous, MEM .
JOURNAL OF MEDICAL GENETICS, 1996, 33 (03) :256-257
[5]   Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1 [J].
Bourdeau, A ;
Cymerman, U ;
Paquet, ME ;
Meschino, W ;
McKinnon, WC ;
Guttmacher, AE ;
Becker, L ;
Letarte, M .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) :911-923
[6]   Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family [J].
Buscarini, E ;
Buscarini, L ;
Danesino, C ;
Piantanida, M ;
Civardi, G ;
Quaretti, P ;
Rossi, S ;
DiStasi, M ;
Silva, M .
JOURNAL OF HEPATOLOGY, 1997, 26 (01) :111-118
[7]   A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5 [J].
Cole, SG ;
Begbie, ME ;
Wallace, GMF ;
Shovlin, CL .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (07) :577-582
[8]  
COTES JE, 1993, LUNG FUNCTION ASSESS, P253
[9]   Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia [J].
Cottin, V ;
Plauchu, H ;
Bayle, JY ;
Barthelet, M ;
Revel, D ;
Cordier, JF .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (09) :994-1000
[10]   Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life [J].
Easey, AJ ;
Wallace, GMF ;
Hughes, JMB ;
Jackson, JE ;
Taylor, WJ ;
Shovlin, CL .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (06) :743-748